ENTA

ENTA Operating Cash Flow (Statement)

-$35.32MTTM · USD

Period ending:

ENTA FY Cash from OperationsUSD
ENTA FY Cash from Operations2010-09-30: -$10.18M2011-09-30: $24.02M2012-09-30: $22.62M2013-09-30: $10.65M2014-09-30: $20.18M2015-09-30: $76.67M2016-09-30: $35.81M2017-09-30: $52.65M2018-09-30: $29.22M2019-09-30: $71.42M2020-09-30: $7.09M2021-09-30: -$70.00M2022-09-30: -$84.78M2023-09-30: -$103.15M2024-09-30: -$78.76M2025-09-30: -$19.27M$76.67M-$103.15M
2010-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ENTA operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 16 observations from Sep 30, 2010 to Sep 30, 2025.

Enanta Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-19,272,000
-78,764,000
-103,154,000
-84,782,000
-69,996,000
7,088,000
71,418,000
29,220,000
52,653,000
35,809,000
76,673,000
20,179,000
10,653,000
22,623,000
24,019,000
-10,175,000

Compare operating cash flow (statement)

All ENTA financial metrics · ENTA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.